Hosted on MSN1mon
Relay Therapeutics CEO Sanjiv Patel sells $1.76 million in stockRelay Therapeutics' Phase 1 ReDiscover trial also demonstrated promising results, leading to adjustments in analysts' outlooks. These recent developments reflect the company's progress in drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback